MTOR and prostate cancer: For upregulated miRNAs in EBV-positive PCa tissues, we observed enrichment of pathways related to renal cell carcinoma (RCC), miRNAs in cancer, prostate cancer, chronic myeloid leukemia, Ras, MTOR, and PI3K-Akt signaling pathways, among others (Fig. 3C).